Suven Life Sciences was incorporated in 1989. The company is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class therapies through the use of GPCR targets. It has six internally-discovered therapeutic drug candidates currently, in pre-clinical stage of development targeting conditions such as ADHD, dementia, depression, Huntington's disease. Parkinson's disease and obesity are in addition to developmental candidate SUVN-502 for Alzheimer's disease and Schizophrenia.
The company is listed on BSE and NSE.
Below you will find details about Suven Life Sciences Company Profile, Share Price, News, Address, Management, Registrar and Contact Details.
|
Karvy Computershare Private Ltd. "Karvy House"
46, Avenue 4,
Street No. 1,
Banjara Hills
Tel: 040-23312454, 23320251/751/752
Fax: 040-23311968
|